Objective: The Ski gene regulates skeletal muscle differentiation in vitro and and in vivo. In the c-Ski overexpression mouse model there occurs marked skeletal muscle hypertrophy with decreased adipose tissue mass. In this study, we have investigated the underlying molecular mechanisms responsible for the increased skeletal muscle and decreased adipose tissue mass in the c-Ski mouse. Approach: Growth and body composition analysis (tissue weights and dual energy X-ray absorptiometry) coupled with skeletal muscle and white adipose gene expression and metabolic phenotyping in c-Ski mice and wild-type (WT) littermate controls was performed. Results: The growth and body composition studies confirmed the early onset of accelerated body growth, with increased lean mass and decreased fat mass in the c-Ski mice. Gene expression analysis in skeletal muscle from c-Ski mice compared with WT mice showed significant differences in myogenic and lipogenic gene expressions that are consistent with the body composition phenotype. Skeletal muscle of c-Ski mice had significantly repressed Smad1, 4, 7 and myostatin gene expression and elevated myogenin, myocyte enhancer factor 2, insulin-like growth factor-1 receptor and insulin-like growth factor-2 expression. Strikingly, expression of the mRNAs encoding the master lipogenic regulators, sterol-regulatory enhancer binding protein 1c (SREBP1c), and the nuclear receptor liver X-receptor-a, and their downstream target genes, SCD-1 and FAS, were suppressed in skeletal muscle of c-Ski mice, as were the expressions of other nuclear receptors involved in adipogenesis and metabolism, such as peroxisome proliferator-activated receptor-g, glucocorticoid receptor and retinoic acid receptor-related orphan receptor-a. Transfection analysis demonstrated Ski repressed the SREBP1c promoter. Moreover, palmitate oxidation and oxidative enzyme activity was increased in skeletal muscle of c-Ski mice. These results suggest that the Ski phenotype involves attenuated lipogenesis, decreased myostatin signalling, coupled to increased myogenesis and fatty acid oxidation. Conclusion: Ski regulates several genetic programs and signalling pathways that regulate skeletal muscle and adipose mass to influence body composition development, suggesting that Ski may have a role in risk for obesity and metabolic disease.
Introduction
The c-Ski proto-oncogene has major roles in controlling cell proliferation and skeletal muscle differentiation in vitro and in vivo. [1] [2] [3] Originally cloned from acute transforming retroviruses through homology to the viral oncogene v-Ski, 4 c-Ski functions as an oncogenic protein and induces myotube formation of quail embryonic fibroblasts. 5 Transgenic mice that overexpress the c-Ski gene display skeletal muscle hypertrophy and by contrast, a marked decrease in adipose tissue mass. 2 The dramatic increase in skeletal muscle mass in the c-Ski transgenic mouse model involves selective hypertrophy of the type IIb 'fast twitch' fibres. The slow twitch oxidative type 1 and IIa fibres do not appear to be enlarged. 2, 6 Ski is a repressor of the transforming growth factor-b (TGF-b) signalling pathway and interacts directly with the signal transduction proteins, Smad1-4 in the nucleus. [7] [8] [9] [10] The TGF-b signalling family consists of multifunctional proteins that regulate the growth, differentiation, apoptosis and morphogenesis of a wide variety of cells. 11 In addition, a ligand belonging to the TGF-b superfamily, myostatin, has been described as a potent negative regulator of skeletal muscle growth and promoter of adipogenesis. 12, 13 Skeletal muscle differentiation requires the action of two groups of regulatory transcription factors: muscle regulatory factors of the MyoD family (muscle-specific b-helix-loop-helix proteins) including MyoD and its relatives Myf5, myogenin and muscle regulatory factor 4, and the myocyte enhancer factor 2 (MEF2_MADS (MCM1, agamous, deficiens, serum reponse factor) box proteins) family that includes myocyte enhancer factor 2 (MEF2) and E proteins. 14 The muscle regulatory factors with MEF2 family proteins coordinate the action of many different co-activators and co-repressors and signalling proteins (for example, p38 kinase) to control myogenesis. Nuclear Ski enhances muscle differentiation through modulation of myogenin promoter activity 15 through activation of the MyoD-myocyte enhancer factor 2 (MEF2) complex and inhibition of histone deacetylase activity. 16 Ski has also been reported to activate the enhancer/promoter of myosin light chain 1/3 and muscle creatine kinase. 17 In addition to its role in TGF-b signalling, Ski acts as a repressor of a diverse range array of other transcription factor signalling pathways. These include nuclear hormone receptors (NRs), such as retinoic acid receptor 18, 19 and thyroid hormone receptor with a Mad-histone deacetylase complex, 20 and transcription factors involved in erythroid and macrophage differentiation, such as PU.1 and GATA1, respectively. [20] [21] [22] Although several studies have examined the physiological effects of skeletal muscle hypertrophy in the Ski transgenic mouse, almost nothing is known about the mechanisms that mediate the decreased adiposity of these mice and whether Ski alters skeletal muscle metabolism or metabolic gene expression in target tissues, such as skeletal muscle or adipose tissue. 2 Moreover, although in vitro studies have identified several muscle-specific differentiation transcription factors that Ski regulates in the b-helix-loop-helix and MADS box protein family, such as MyoD and myogenin, 15, 16 the role of c-Ski in modulation of other gene targets known to be involved in skeletal muscle hypertrophy has not been examined. Skeletal muscle accounts for B40% of the total body mass and energy expenditure. Moreover, it is very dependent on fatty acid and glucose oxidation to meet its energy demands. Consequently, this organ has a significant role in lipid, glucose and energy homeostasis. The decreased adiposity of c-Ski mice, may involve the onerous metabolic demands of the significantly larger lean tissue mass. We hypothesize that Ski-mediated skeletal muscle hypertrophy alters the balance between fatty acid oxidation and lipogenesis to meet the altered metabolic demands of this mouse model.
In this study, we have re-evaluated the growth pattern and body composition in the c-Ski mouse and correlated these physiological findings to changes in gene expression (controlling metabolism) and several metabolic parameters in skeletal muscle and adipose tissue. We show that the c-Ski mice have an altered gene expression footprint that may explain the lean and hypertrophic phenotype. Strikingly, skeletal muscle of c-Ski mice display concordant changes in several genetic programs that include increased muscle mass, decreased adiposity and suppressed lipogenesis. Moreover, c-Ski mice seem to have increased fatty-acid b-oxidation. These results suggest that Ski targets several signalling pathways that promote increased muscle mass and decreased adiposity. This mouse model provides insights into potential pathways that may be therapeutically modulated in lean tissue to treat obesity and metabolic disease.
Materials and methods

Animals and tissues collection
The c-Ski transgenic mice (line 8566) that express chicken c-Ski cDNA under control of the murine sarcoma virus long terminal repeat (MSV, LTR) mouse were originally obtained from Stephen Hughes (NIH, Bethesda, MD, USA) 23 
Food intake
The protocol developed by the Jackson Laboratories (Bar Harbor, ME, USA) was used. Food intake was determined to the nearest 0.1 g by weighing the metal cage top containing the food each day. In previous tests, using this procedure we have shown that food spillage does not exceed 0.1 g day À1 per mouse. Total food intake of 15-week-old mice was measured per mouse box (2-3 mice of the same genotype per box) for five consecutive days to obtain average daily food intake per mouse.
Histology
Tissues were fixed in 10% buffered formalin, paraffinembedded and sections of liver, brown and white adipose tissues were stained with hematoxylin and eosin.
Dual energy X-ray absoptiometry and tissues weight analysis Whole animals were placed in a Mouse GE Lunar PIXImus Densitometer (GE Healthcare, Piscataway, NJ, USA) to determine total body fat and lean tissue composition as described previously. 24 Tissue weights were determined on 14-16 h fasted mice after cervical disslocation. 
Quantitative RT-PCR
RNA extraction and cDNA synthesis Total RNA from liver, skeletal muscle and pancreas was extracted using TRI reagent and a handheld ultra-turrax homogenizer (IKA, Staufen, Germany) and purified using the RNeasy mini kit (Qiagen, Valencia, CA, USA). The same procedure was used for white and brown adipose tissues with the exception that Qiazol was used instead of TRI reagent. Reverse transcription was performed using 1 mg of total RNA in each cDNA synthesis reaction. 25 Blood and serum analysis Glucose tolerance tests (2 g kg À1 glucose i.p.) were performed in overnight-fasted mice. Blood samples were obtained from the tail tip at the indicated times, and glucose levels were measured using a glucometer (AccuCheck II; Roche, Basel, Switzerland). Insulin was assayed by radioimmunoassay (Linco Research, St Louis, MO, USA). The concentrations of non-esterified fatty acids (Wako Pure Chemical Industries, Osaka, Japan) and triglycerides (Roche Diagnostics) were determined using a colorimetric kit. Serum levels of IGF-1, IGF-2, leptin and adiponectin were measured using Milliplex kits (Millipore, St Charles, MO, USA) and a Mediagnost Kit according to the manufacturer's protocol.
Homogenate oxidations
Palmitate oxidation were measured in muscle homogenates using a modified method described previously. 27, 28 Briefly, C]palmitate (0.5 mCi). After 90 min of incubation at 30 1C, the reaction was stopped by the addition of 100 ml of ice-cold 1 mol l À1 perchloric acid. Carbon dioxide produced during the incubation was collected in 100 ml of 1 mol l À1 sodium hydroxide. The 14 C counts present in the acid-soluble fraction were also measured and combined with the CO 2 values to give the total palmitate oxidation rate. Protein content in the homogenates were measured using the Bradford method (Protein Assay Kit; Bio-Rad Laboratories, Regents Park, Australia).
Enzyme activity measurements
Powdered muscle samples were homogenized 1:19 (wt/vol) in 50 mmol l À1 Tris-HCl, 1 mmol l À1 EDTA and 0.1% Triton X-100 (pH 7.2), using a Polytron instrument (Kinematica, Littau-Lucerne, Switzerland) and were subjected to three freeze-thaw cycles. Cytochrome c oxidase, citrate synthase and b-hydroxyacyl CoA dehydrogenase levels were determined at 30 1C, as described previously, 28 using a Spectra
Max 250 microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
C2C12 cell culture, transfection and luciferase assay
The effect of Ski on SREBP1c promoter activity was tested by transiently transfecting C2C12 cells with a luciferase reporter plasmid (pGL3-SREBP1c) 29 and a c-Ski expression plasmid (pCS2 þ MT-cSki; a kind gift of M. Hayman, Stony Brook University, NY, USA). Each well of a 24-well plate of C2C12 cells (30% confluence) was transfected with a total of 0.5 mg of DNA consisting of 0.3 mg pGL3-SREBP1c reporter and either 0, 10, 50, 100 or 200 ng of pCS2 þ MT-cSki with total pCS2 þ MT plasmid DNA made up to 200 ng with pCS2 þ MT (empty vector). A liposome-mediated transfection procedure was used as previously described. 25 Cells were transfected 
Statistical analysis
Unless stated otherwise, all data were analysed using a t-test on GraphPad Prism 4 software package (La Jolla, CA, USA).
Results
Ski transgenic mice have early post-natal enhancement of growth with increased lean mass and decreased fat mass Although, previous studies of the c-Ski mice have shown altered skeletal muscle mass with profound enlargement of specific skeletal muscle types involving type II fibres, a detailed examination of the alterations in adipose tissue mass in the c-Ski mice have not been previously undertaken. 2 We confirmed the findings of previous studies of the c-Ski mouse model by performing a growth analysis of both male and female Ski and wild-type (WT) littermate mice. To the best of our knowledge such a detailed growth curve has not been previously published. c-Ski mice have early post-natal enhancement of body weight that is readily apparent by 6-8 weeks of age when both male and female c-Ski mice are significantly heavier than WT littermate mice (Figure 1a) . By maturity at 15 weeks of age, the c-Ski mice have a 25-30% increase in body weight compared with their WT controls. The change in body size was accompanied by a significant increase in food intake in c-Ski mice compared with WT mice (Figure 1b) .
We performed a longitudinal growth curve analysis of WT and c-Ski mice using a multilevel mixed effects linear regression. The change in weight of the mice over time was found to be non-linear in all groups (males/females; transgenic/WT). Two models were developed predicting mouse weight using time, time squared and sex for each mouse genotype. Growth curves for c-Ski transgenic and WT mice were compared and found to be significantly different from each other ( Table 1) . A statistically significant interaction effect was observed between mouse genotype and time (Table 2 ). This confirmed that the coefficient for time is significantly different between WT and c-Ski transgenic mice.
Body composition studies using dual energy X-ray absorptiometry (Figures 1c and d) and analysis of organ weights (Figure 2a ) confirmed that the increase in body weight in the Ski mice is associated with increase in size relative to body weight of muscles with predominately type 2 fibres (tibialis anterior and extensor digitorum longus) with no change in the type 1 fibre predominant soleus and mixed fibre-type Ski proto-oncogene GM Leong et al profound effect that Ski overexpression has on both muscle and adipose tissue mass in this mouse model.
Endogenous Ski and ectopic c-Ski expression in transgenic mice: c-Ski specifically expressed in type II fibres To confirm whether c-Ski transgene expression had any effect on endogenous levels of Ski expression, we performed quantitative RT-PCR (qRT-PCR), using primers specific for murine Ski and c-Ski, on various tissues (Figure 3 ). When compared with WT mice there appeared to be no alteration in endogenous levels of Ski in the c-Ski TG mice in any of the tissues studied. Furthermore, this analysis confirmed that ectopic c-Ski expression is largely confined to Type II skeletal muscle fibres with levels of transgene expression highest in fast-fibre-predominant muscles (tibialis anterior and gastrocnemius) and lowest in the slow-fibre-predominant soleus muscle. 2 Interestingly, c-Ski transgene expression was also expressed at lower levels in white and brown adipose tissue and liver, whereas its expression was undetectable in pancreas ( Figure 3 ).
Ectopic Ski expression leads to repression of the TGF-b signalling gene expression The mechanisms that mediate increased muscle mass and decreased adiposity in the c-Ski mice have not been investigated. To address this question, we first performed qRT-PCR expression analysis of genes that are known to regulate skeletal muscle mass. Ski is a major negative regulator of the TGF-b signalling pathway involved in cell proliferation. Accordingly, we examined the expression of several members of this pathway, including the Smad transducer proteins, the negative regulator of muscle mass, myostatin and the activin receptor type 2B (ACVR2B; Figure 4a ). In c-Ski mice, the bone morphogenetic proteinspecific Smad 1, and Co-Smad 4 and reverse Smad 7 were all significantly repressed compared with WT mice. There was a trend towards a decrease in expression of the TGF-b-specific Smads 2 and 3 and inhibitory Smad 6 and ACVR2B in c-Ski mice compared with WT mice, however, the changes did not attain significance (Smad2 P ¼ 0.14, Smad3 P ¼ 0.08, Smad 6 P ¼ 0.21 and ACVR2B P ¼ 0.08). In concordance with the increased muscle mass and decreased adiposity in the c-Ski mice, the skeletal muscle from c-Ski mice expressed significantly decreased levels of the mRNA encoding myostatin.
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Ectopic c-Ski expression differentially regulates helix-loophelix, MADs box and growth hormone receptor-IGF-1 gene expression Previous reports have demonstrated that Ski activates myogenin expression and promoter activity. 15 Consistent with these observations, we show that Ski skeletal muscle expresses markedly increased levels of the mRNA encoding myogenin relative to WT muscle (Figure 4b ). Moreover, we show differential effects in the c-Ski mice on other skeletal muscle factors, such as MEF2c and MyoD, with opposite effects on expression patterns of these myogenic regulators. 30 Interestingly, Ski also seems to alter the expression of the growth hormone receptor and IGF signalling pathways, which have roles in skeletal muscle and adipose growth and development. [31] [32] [33] In the c-Ski mice, expression of insulin-like growth factor 1 receptor and IGF-2 was increased, especially of IGF-2, whereas those of IGF-1 and growth hormone receptor decreased (Figure 4b ). To determine whether these differences in mRNA expression were associated with circulating serum levels of IGF-1 and IGF-2, we measured these growth factors in serum. No significant differences were observed in serum IGF-1 or IGF-2 level between the WT and Ski mice with IGF-1 level (ng ml
À1
) in WT being 147±28 (mean±s.e.m.) and in c-Ski mice 150 ± 37 (n ¼ 7 per group), respectively, and IGF-2 level (ng ml À1 ) in WT being 27.8 ± 1.5 and in c-Ski mice 34.6±5.3 (n ¼ 7 mice per group), respectively.
Ski represses lipogenic gene expression Additional candidate-based expression profiling revealed that lipogenic gene expression was suppressed in c-Ski mice, relative to WT littermate mice ( Figure 5 ). For example, qRT-PCR revealed that in the c-Ski mice, the greatest decrease in gene expression was in the mRNA encoding SREBP1c, the master lipogenic regulator. As insulin is a major activator of SREBP1c expression, we analysed mice in both fasted (low-insulin state) and non-fasted (higher insulin) states. This revealed that there was a greater-fold repression of SREBP1c expression in c-Ski mice in the non-fasted higher insulin state (Figure 5a ) with a blunting of the Ski-dependent gene repression in the fasted state. Moreover, two major downstream targets of SREBP1c, SCD-1 and FAS were both suppressed in the non-fasted state, whereas SCD-1, but not FAS, was significantly suppressed in the fasted state (Figure 5a ). The expression of several NRs involved in the control of lipogenesis, lipid storage and metabolism was repressed in the c-Ski mice. These included the expression of the LXRa, PPARg, GR and the orphan NR, RORa (Figure 5b ). Ski proto-oncogene GM Leong et al Interestingly, LXR and RORa have been described previously, as regulators of the SREBP1c promoter, in several cell lines derived from hepatic, adipose and muscle tissue and also in vivo. 26, 34 In this context, LXR has also been reported to regulate the SCD-1 and FAS promoters. 35, 36 This suggests that Ski suppresses the expression of the two major regulators of lipogenesis, and this significantly affects the expression of the downstream target genes, SCD-1 and FAS, which are involved in fatty acid biosynthesis.
Ski represses the SREBP1c promoter The nuclear receptor LXR (in an agonist-dependent manner) and the orphan RORa have been demonstrated to transactivate the SREBP1c promoter in co-transfection experiments. 25, 29 We thus examined whether co-transfected Ski transcriptionally regulated the activity of the SREBP1c promoter. Transfection analysis in C2C12 myogenic cells revealed that Ski repressed SREBP1c promoter activity in a dose-dependent manner (Figure 5c ). 34 Interestingly, Ski co-transfection did not suppress LXR agonist-dependent induction. In concordance, mutation of the LXR-binding sites in the SREBP1c promoter did not affect Ski-mediated repression of the SREBP1c promoter (data not shown).
White adipose tissue from c-Ski mice have unaltered metabolic gene expression To determine in white adipose tissue the pattern of gene expression in c-Ski versus WT mice, we performed a Taqman low density array experiment using a custom-made metabolic card with 96 genes known to be involved in metabolism (see Supplementary data). This analysis identified three possible candidate genes whose expression was potentially altered in c-Ski mice compared with WT mice. The increased expression in the c-Ski mice of cyclooxygenase 2 by 1.5-fold (log scale), myostatin by 2.2-fold and MEF2c by 3.64-fold, however, failed to reach statistical significance (see Supplementary data). In addition, no significant differences were observed in mRNA expression performed by qRT-PCR in the c-Ski mice compared with WT mice in these three transcripts and the nuclear receptors LXRa, GR or PPARg (data not shown).
Skeletal muscle of c-Ski mice display increased rates of fatty acid oxidation Gene expression profiling suggests that skeletal muscle from c-Ski mice has reduced lipogenic activity. To determine whether this is coupled to alterations in oxidative capacity, which may contribute to decreased adiposity, we performed palmitate oxidation experiments in skeletal muscle and measured the activity of several enzymes linked with oxidative metabolism, including cytochrome c oxidase, citrate synthase and hydroxyacyl-CoA dehyrogenase ( Figure 6 ). 28 These studies were performed on quadricep skeletal muscle, which like the gastrocnemius muscle displayed decreased expression of the lipogenic regulator, SREBP1c, in c-Ski mice relative to WT mice (data not shown). Ski proto-oncogene GM Leong et al
We found that skeletal muscle of c-Ski mice had significantly increased palmitate oxidation and significantly elevated activity of oxidative enzymes compared with WT mice. In the c-Ski mice, an increased enzyme activity was observed for cytochrome c oxidase, citrate synthase and hydroxyacyl-CoA dehydrogenase.
Circulating lipids, insulin, adiponectin and glucose tolerance in c-Ski mice Consistent with the lean phenotype of the c-Ski mice, we observed significantly decreased serum levels of leptin and adiponectin, whereas no significant differences in fasting insulin, non-esterified fatty acid or triglyceride levels were observed (Figure 7a ). To investigate the effects of the lean phenotype on glucose tolerance, we performed glucose tolerance tests on Ski and WT littermate controls. Interestingly, glucose tolerance in c-Ski mice was mildly impaired compared with WT littermate controls (Po0.05; Figure 7b ).
Discussion
The paramount role of the Ski gene in myogenesis and TGF-b signalling has been well-characterized in vitro and in vivo.
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Although, the original description of the c-Ski transgenic mouse model showed increased muscle mass and reduced adiposity in these mice, the underlying mechanism for this latter effect has remained obscure. In this study, candidatebased expression profiling demonstrates that the skeletal muscle of c-Ski transgenic mice display aberrant expression of several critical transcriptional cascades that control myogenic and lipogenic signalling pathways that influence body composition. For example, Ski expression leads to: (i) attenuation of Smad gene expression; (ii) suppression of myostatin expression; (iii) increased myogenin, MEF2c, insulin-like growth factor 1 receptor and IGF-2 expression; and (iv) decreased expression of LXRa, PPARg, RORa and SREBP1c (and the downstream lipogenic target genes). These nuclear hormone receptors and SREBP1c are hierarchical regulators of fatty acid biosynthesis and storage.
In keeping with Ski's role in suppressing Smad-dependent TGF-b signalling, c-Ski mice had decreased expression of Smad1, 4 and 7 and myostatin expression. Myostatin, a TGFb superfamily member, operates in an opposing manner in skeletal muscle and adipose tissue. For example, myostatin is a negative regulator of skeletal muscle mass and it induces adiposity by promoting adipogenesis. 12, 37, 38 Myostatindeficient mice and humans have increased muscle mass and decreased adipose tissue mass. 37 Ski suppression of myostatin and GR expression, a transcriptional activator of the myostatin promoter, 39 Ski proto-oncogene GM Leong et al repression of MyoD suggests that Ski targets several myogenic differentiation genes. The alteration of genes involved in the GH-IGF system also implicates a role for Ski in growth factor regulation of both skeletal muscle and adipose mass. We observed a marked increase in IGF-2 and insulin-like growth factor 1 receptor mRNA levels, but a compensatory decrease in IGF-1 and GHR mRNA levels. 40 In particular, IGF-2 expression was markedly elevated in Ski skeletal muscle. Both IGF-1 and IGF-2 are critically involved in skeletal muscle development, with IGF-2 autocrine actions being essential for the differentiation of satellite cells. 31 Amino acid and mammalian target of rapamycin (mTOR) signalling has been shown to control IGF-2 transcription in skeletal muscle cells, 33 which acts through the insulin-like growth factor 1 receptor to alter phosphoinositide 3-kinase (PI3K)-Akt pathway and, therefore, promotes myogenesis and decreases adipogenesis. 32 Interestingly, we observed decreased expression of several nuclear hormone receptors that have been implicated in a 'fatty' phenotype, including LXRa, PPARg, RORa and the GR. Furthermore, the mRNA encoding SREBP1c (a master regulator of lipogenesis) and its downstream fatty acid biosynthetic target genes, FAS and SCD-1 were decreased in Ski mice. SREBP1c is an important LXR and ROR target gene, expression of which is elevated in skeletal muscle from morbidly obese patients, and decreases with weight loss in conjunction with reductions in intramyocellular lipid and improvements in insulin sensitivity. 41 In this context, it is interesting to note that mouse models with attenuated LXRa and RORa expression display reduced adiposity and resistance to diet-induced obesity. 26 Overall, the NR expression footprint observed in the c-Ski mice is concordant with reduced lipogenesis that presumably contributes, in part, to the lean phenotype of these animals. The reduced adiposity in c-Ski mice is also associated with increased skeletal muscle fatty acid oxidative capacity. Several other genetically manipulated mouse models have a lean phenotype that seems to be driven, in part, by elevated fat oxidation in skeletal muscle. [42] [43] [44] Of these lean Ski proto-oncogene GM Leong et al humans, 45 mice 42 and in L6 myotubes. 46 Our finding that Ski represses the expression of lipogenic genes, such as SCD1, therefore, provides a potential explanation for the increased fatty acid oxidation observed in skeletal muscle of the c-Ski mice. Alternatively, alterations of physical activity or thermogenesis may explain the reduced adiposity of the c-Ski mice. An analysis of these other potential contributing factors to the lean phenotype of the c-Ski mice is the focus of current studies. The finding of mild glucose intolerance in c-Ski mice compared with WT littermates controls was surprising, but may be consistent with our observation in the c-Ski mice of a reduction in PPARg expression in skeletal muscle and reduced adiposity, and also decreased adiponectin levels observed in the c-Ski mice. 47, 48 Interestingly, knockout of the PPARg gene in skeletal muscle leads to severe glucose intolerance. 49 In addition, these PPARg-deficient mice have progressive severe insulin resistance with aging. 49 In contrast to the c-Ski mouse the PPARg mice have increased body fat as evidenced by heavier epididymal fat pads than their WT littermate controls. 49 Presumably as the c-Ski mice still do have detectable levels of PPARg expression though an overall repressed lipogenic gene profile (including decreased levels of other NRs, such as GR, LXRa and RORa), the degree of glucose metabolism is not severely impaired at least on a normal chow diet. It will be thus interesting to determine in future studies whether the c-Ski mice are resistant to dietinduced obesity and whether a high-fat diet may alter glucose tolerance and insulin sensitivity. The overall depots of both white and brown adipose tissues were significantly decreased in c-Ski mice, raising the possibility that adipose gene expression may be altered in the c-Ski mice. Our examination of gene expression changes in white adipose tissue failed to show any significant changes in the 96 genes we studied in the c-Ski mice. Interestingly, recent evidence suggests that brown adipose tissue and skeletal muscle are derived from the same cell lineage from myogenic factor-5 (Myf-5)-expressing cells. 50 Though our results suggest Ski alters adipose tissue development through effects on skeletal muscle gene expression and metabolism, further studies will be required to determine whether Ski directly regulates white and brown adipocyte differentiation.
In summary, in these new studies we have shown that the proto-oncogene Ski targets the master lipogenic regulator SREBP1c and several NRs involved in adipogenesis and metabolism in skeletal muscle. These results and those we present regarding Ski's effects on skeletal muscle metabolism and energy expenditure suggest that Ski may have a major role in body composition development and hence risk for obesity and metabolic disease.
